MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Adamis Pharmaceuticals Corp Company Profile (NASDAQ:ADMP)

Consensus Ratings for Adamis Pharmaceuticals Corp (NASDAQ:ADMP) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.00 (138.66% upside)

Analysts' Ratings History for Adamis Pharmaceuticals Corp (NASDAQ:ADMP)
Show:
DateFirmActionRatingPrice TargetActions
5/29/2015MizuhoInitiated CoverageBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2014CRT CapitalReiterated RatingPositive$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2014CRT CapitalInitiated CoverageBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/3/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha